D-0241-2026 Class II Ongoing
Recall Details
- Product Type
- Drugs
- Report Date
- December 31, 2025
- Initiation Date
- December 12, 2025
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3 - single dose kits
Product Description
Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03
Reason for Recall
Presence of particulate matter: potential presence of metal particulates in the product.
Distribution Pattern
Nationwide in the USA
Code Information
Lot #: Z014503, Exp 11/15/2027